Drug recall · December 4, 2019
DG Health Acid Reducer Ranitidine Tablets 150 mg recall
Why: CGMP Deviations: N-nitrosodimethylamine (NDMA) has been detected in Ranitidine tablets, capsules and syrups.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
DG Health Acid Reducer Ranitidine Tablets 150 mg, 8-count carton, Distributed by: Dolgencorp LLC 100 Mission Ridge Goodletville TN 37072 NDC 55910-092-79
- Lots / codes
Lot # NBSB19001DA3; Exp FEB 2021
- Quantity
- 69,696 bottles
- Company
- AuroMedics Pharma LLC, East Windsor, NJ
- Distribution
- nationwide
- Initiated
- November 6, 2019 · Voluntary: Firm initiated
- Classified
- November 26, 2019
- Reported
- December 4, 2019
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ranitidine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.